Back to top
Top

["Diagnosis": "Mixed histology urothelial cell carcinoma for Urology Care"]

Performance/Reporting Period
2022
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to identify concepts of mixed histology urothelial cell abnormalities.
Data Element Scope: This value set may use a model element related to Diagnosis.
Inclusion Criteria: Includes concepts that identify a diagnosis of urothelial cell abnormalities.
Exclusion Criteria: Excludes concepts that indicate a condition for other urothelial cell abnormalities in the urinary bladder.

Constrained to codes in the Diagnosis: Mixed histology urothelial cell carcinoma for Urology Care value set (2.16.840.1.113762.1.4.1151.39)

QDM Datatype and Definition (QDM Version 5.5 Guidance Update)

"Diagnosis"

Data elements that meet criteria using this datatype should document the Condition/Diagnosis/Problem and its corresponding value set. The onset dateTime corresponds to the implicit start dateTime of the datatype and the abatement dateTime corresponds to the implicit stop dateTime of the datatype. If the abatement dateTime is not present, then the diagnosis is considered to still be active. When this datatype is used with timing relationships, the criterion is looking for an active diagnosis for the time frame indicated by the timing relationships.

Timing: The prevalencePeriod references the time from the onset date to the abatement date.

QDM Attributes

prevalencePeriod

Prevalance Period is the time from onset dateTime to abatement dateTime.
Last Updated: Jul 08, 2021